Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Evoke Pharma Inc.

Start price
Target price
Perf. (%)
€0.94
23.09.23
-
23.09.24
-63.64%
24.09.24

StockNews.com 
23.09.23 50%
buy
R1 RCM Inc.

Start price
Target price
Perf. (%)
€14.40
22.09.23
€20.64
22.09.24
-12.50%
23.09.24

Royal Bank of Canada 
22.09.23 50%
buy
R1 RCM Inc.

Start price
Target price
Perf. (%)
€14.00
22.09.23
€18.76
22.09.24
-10.00%
23.09.24

Citigroup Inc. 
22.09.23 50%
buy
Agile Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.21
22.09.23
-
22.09.24
-
23.09.24

Maxim Group 
22.09.23 50%
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€1.02
21.09.23
-
21.09.24
-7.27%
01.10.23

Could be very worthwhile Investment >20% year
Wolf_of_WS 
21.09.23 50%
buy
Incyte Corp.

Start price
Target price
Perf. (%)
€55.16
21.09.23
€85.28
21.09.24
7.58%
22.09.24

Truist Financial Co. 
21.09.23 50%
buy
Incyte Corp.

Start price
Target price
Perf. (%)
€55.16
21.09.23
€85.28
21.09.24
7.58%
22.09.24

Truist Financial Co. 
21.09.23 50%
buy
Boston Scientific

Start price
Target price
Perf. (%)
€50.76
21.09.23
€57.16
21.09.24
47.75%
22.09.24

Truist Financial Co. 
21.09.23 50%
buy
Boston Scientific

Start price
Target price
Perf. (%)
€50.76
21.09.23
€59.08
21.09.24
47.75%
22.09.24

Citigroup Inc. 
21.09.23 50%
buy
Boston Scientific

Start price
Target price
Perf. (%)
€50.76
21.09.23
€57.21
21.09.24
47.75%
22.09.24

Royal Bank of Canada 
21.09.23 50%
buy
Laboratory Corp. Of America (labcorp)

Start price
Target price
Perf. (%)
€194.00
21.09.23
€215.69
21.09.24
1.19%
22.09.24

Bank of America Co. 
21.09.23 50%
buy
Boston Scientific

Start price
Target price
Perf. (%)
€50.76
21.09.23
€60.02
21.09.24
47.75%
22.09.24

BTIG Research 
21.09.23 50%
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€1.25
20.09.23
-
20.09.24
-24.48%
02.10.23

Could be worthwhile Investment >10% per year
thomasw 
20.09.23 50%
buy
Boston Scientific

Start price
Target price
Perf. (%)
€51.34
20.09.23
€57.00
20.09.24
46.08%
21.09.24

Needham & Company LLC 
20.09.23 50%
buy
Boston Scientific

Start price
Target price
Perf. (%)
€49.65
19.09.23
€56.11
19.09.24
52.06%
20.09.24

Evercore ISI 
19.09.23 50%
buy
Insmed Inc.

Start price
Target price
Perf. (%)
€24.40
19.09.23
€43.04
19.09.24
172.54%
20.09.24

Cantor Fitzgerald 
19.09.23 50%
buy
QuidelOrtho Corp.

Start price
Target price
Perf. (%)
€70.92
19.09.23
€131.00
19.09.24
-42.47%
20.09.24

Royal Bank of Canada 
19.09.23 50%
sell
PTC Therapeutics Inc.

Start price
Target price
Perf. (%)
€23.20
19.09.23
€21.49
19.09.24
37.93%
20.09.24

Bank of America Co. 
19.09.23 50%
buy
Enanta Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€11.80
19.09.23
€44.85
19.09.24
-16.10%
20.09.24

HC Wainwright 
19.09.23 50%
buy
Lightpath Techs A

Start price
Target price
Perf. (%)
€1.41
19.09.23
€2.80
19.09.24
-24.11%
20.09.24

HC Wainwright 
19.09.23 50%
sell
MicroVision Inc

Start price
Target price
Perf. (%)
€2.02
19.09.23
€4.00
19.09.24
4.43%
27.09.23

Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Traumtanz 
19.09.23 50%
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€246.80
19.09.23
€250.00
19.09.24
4.13%
27.09.23

Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Traumtanz 
19.09.23 50%
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€246.80
19.09.23
€250.00
19.09.24
4.13%
27.09.23

Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Traumtanz 
19.09.23 50%
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€246.80
19.09.23
€250.00
19.09.24
4.13%
27.09.23

Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Traumtanz 
19.09.23 50%
sell
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€533.50
19.09.23
€558.00
19.09.24
6.56%
11.10.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
19.09.23 50%